Temasek last year was exploring a sale of the Singapore-based company at a US$1 billion valuation, according to the people. Negotiations later hit a snag as the prospective offers did not meet the expectations of the seller, they said.
Singaporean investment firm Temasek Holdings is considering a US initial public offering of Advanced MedTech Holdings after a planned sale of the medical device maker stalled, according to people with knowledge of the matter.
The firm is working with advisers to explore a potential share sale that could raise US$200 million ($265.84 million) to US$300 million, said the people, who asked not to be identified as the information is private. A listing may take place as soon as next year, one of the people said.
